Oncology Medical News about melanoma

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Cytarabine Plus Methotrexate Improves Remission Rates in Patients with Primary CNS Lymphoma

Roberta Buell, MBA
CMS Re-Validates Enrollment of Big Billers

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma
Cancer, 10/22/09

Gajdos C et al. – Clinically lymph node–negative T4 melanoma cases should be strongly considered for SLN biopsy, regardless of Breslow depth. SLN lymph node status is the most significant prognostic sign among these patients. T4 patients with a negative SLN have an excellent prognosis in the absence of ulceration and should not be considered candidates for adjuvant high–dose interferon.

<< Previous
Thromboprophylaxis with low-molecular-weight heparin in medical...

Next >>
Clinical benefits of a multivariate prediction model for bladder...